Clinical

Dataset Information

Effects of intestinal microbiome diversity on the efficacy and survival of chemotherapy combined with immunotherapy and immunotherapy in advanced non-small cell lung cancer


ABSTRACT: Interventions: Group 1:Chemotherapy combined with immunotherapy;Group 2:Immunotherapy Primary outcome(s): CR;PR;SD;PD;PFS;OS;Gut microbiome;Fecal metabolomics;Immune factor Study Design: Non randomized control

DISEASE(S): Non-small Cell Lung Cancer

PROVIDER: 2689155 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR